|
⚲
|
| Keyboard |
| Landry Robert E
✚
|
|
|---|---|
| CIK # | 0001585160 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001585160] | |
| 4 | [0001585160] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Landry Robert E | |
| Cytokinetics Inc | |
| Zymeworks Inc | |
| Regeneron Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zymeworks Inc ZYME
Restricted Stock Unit · derivative
|
2026-01-12 | Grant | 7,700 | $0.00 | |
|
Zymeworks Inc ZYME
Stock Option (Right to Buy) · derivative
|
2026-01-12 | Grant | 11,500 | $0.00 | |
|
Zymeworks Inc ZYME
Stock Option (Right to Buy) · derivative
|
2025-08-11 | Grant | 62,000 | $0.00 | |
|
Cytokinetics Inc CYTK
Common Stock
|
2025-05-14 | Grant | 7,333 | $0.00 | |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2025-05-14 | Grant | 10,880 | $0.00 | |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2025-02-10 | Grant | 25,538 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-02-02 | Option exercise | 400 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-02-02 | Option exercise | 400 | $378.98 | 151,592 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-02-02 | Tax withheld | 281 | $956.65 | 268,819 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-01-31 | Option exercise | 400 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-31 | Tax withheld | 282 | $953.42 | 268,864 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-31 | Option exercise | 400 | $378.98 | 151,592 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-24 | Option exercise | 500 | $378.98 | 189,490 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-24 | Tax withheld | 352 | $951.26 | 334,844 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-01-24 | Option exercise | 500 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-01-23 | Option exercise | 1,100 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-23 | Option exercise | 1,100 | $378.98 | 416,878 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-23 | Tax withheld | 776 | $948.50 | 736,036 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-17 | Tax withheld | 354 | $932.34 | 330,048 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-17 | Option exercise | 500 | $378.98 | 189,490 |
| showing 20 of 200 most recent transactions | |||||